(E)-6-Iodo-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole

We are (E)-6-Iodo-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole CAS:886230-77-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:(E)-6-Iodo-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole
CAS.NO:886230-77-9
Synonyms:6-iodo-1-(oxan-2-yl)-3-(2-pyridin-2-ylethenyl)indazole
Molecular Formula:C19H18IN3O
Molecular Weight:431.27000
 
Physical and Chemical Properties:
Density:1.6
Melting point:156-159ºC
Boiling point:561.2ºC
Flash point:293.2ºC
 
Specification:
Appearance:Light Yellow Solid
Purity(HPLC):≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Axitinib
 
Note:The product under valid patents will not be offered to the countries covered by patents.

(E)-6-Iodo-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole


Related News: Judging from the geographical distribution of enterprises, the largest distribution of API companies is Jiangsu and Zhejiang, with more than 300 enterprises; followed by Shandong, Sichuan and Hubei.141-63-9 Pharmaceutical intermediates and APIs belong to the fine chemical industry.2-fluoro-6-metilpiridina CAS:407-22-7 At the same time, experts said that API companies need to increase investment in environmental protection, carry out industrial upgrades, improve processes, improve pollution treatment capabilities, and then achieve sustainable development in the future, and seize structural opportunities.107-29-9 At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth.From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity.

Related Products
Product Name
2-Bromo-9,9-diphenyl-9H-fluorene View Details
2-Ethyl anthraquinone View Details
1-Bromo-9H-carbazole View Details
Iminostilbene N-Carbonyl Chloride manufacturer 2-(5-Mercaptotetrazole-1-yl)ethanol manufacturer Ethyl formate manufacturer 3,5-Dichlorobenzoyl chloride manufacturer 2-Hydroxy-6-methylpyridine manufacturer